
Elahere, validated in a phase 3 trial, is FDA-approved and offers the first major advancement for platinum-resistant ovarian cancer in decades.

Elahere, validated in a phase 3 trial, is FDA-approved and offers the first major advancement for platinum-resistant ovarian cancer in decades.

In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer.

Clara Mae Cirk, a 30-year-old diagnosed with stage 4 lung cancer, shares how cancer has reshaped her perspective on strength and self-care.

Cancer taught me to embrace life’s seasons, finding hope, joy, and gratitude in each chapter, no matter the struggles I face.

Women with HR+ early breast cancer who paused endocrine therapy to become pregnant breastfed without increased risk of recurrence in the short term.

Kimberly (Cary) Demirhan concludes a three-part series on bringing cancer research to the community setting.

Lung cancer affects up to 25% of non-smokers, so persistent symptoms and genetic testing are key for early detection and treatment.

Women diagnosed with ovarian cancer should consult a fertility specialist immediately, as egg or embryo freezing is most effective before treatment starts.

CURE sat down with Dr. Tanja A. Gruber of Stanford Medicine Children’s Health to discuss clinical trials in infant leukemia.

The FDA approved Monjuvi with Revlimid and Rituxan for follicular lymphoma, the same combination that brought survivor Troy Anderson a lasting response.

Autumn lifts my spirit, reminding me to embrace beauty, family, faith, and gratitude even while living with cancer.

Dr. Monica Avila explains how cancer treatments can trigger early menopause, causing symptoms like hot flashes, mood changes and irregular periods.

FDA grants D3S-001 treatment breakthrough therapy for KRAS G12C some with lung cancer and orphan drug status for KRAS G12C colorectal cancer in adults.

Facing a cancer diagnosis was terrifying, but determination, lifestyle changes, and a strong support system helped me fight and find hope.

Stage 1 melanoma is treatable with surgery, and when combined with early detection, proper care and regular follow-ups, it offers a favorable outlook.

Hideko Warner shared how she faced three cancers at once and became the first in Orange County to receive biology-guided radiation therapy with no side effects.

Clara Mae Cirk, a 30-year-old who was diagnosed with stage 4 lung cancer, opens up about her journey and using social media as an outlet to educate others.

The FDA has granted fast track designation to stenoparib, an investigational therapy for patients with advanced ovarian cancer.

The shift in seasons reminds me I’m alive, grateful, and still changing as a cancer survivor embracing life’s new chapters.

Patients with breast cancer receiving antibody-drug conjugates after chemo can generally expect milder side effects compared with their previous treatment.

Learn about diagnosis, explore your thyroid cancer treatment options and find practical advice for managing side effects and living well after treatment.

Genetic testing before chemotherapy may help improve safety and guide treatment for patients with gastrointestinal cancers.

For many women facing cancer, having a female oncologist can bring an added sense of support and understanding, according to Dr. Tran Ho.

Standing up to cancer means focusing on the blessings, reveling in good news, and living life to its fullest every day.

In HPV15-positive first-line recurrent and/or metastatic head and neck cancer, PDS0101 and Keytruda elicited median overall survival more than three years.

Here is a primer on what patients who have received a diagnosis of gastrointestinal cancer need to know.

FDA-authorized AI tools have the potential to help patients with prostate cancer get clearer answers instead of waiting weeks for genomic test results.

I share practical strategies for living well with cancer, from research and self-care to support, creativity, and wise giving.

Dr. William Audeh explains how treatment decisions for breast cancer can be informed by a patient’s ultra-low, low or high genomic risk status.

Non-drug therapies, counseling and telehealth improved pain, mood and communication in cancer care, though older adults and minorities remain underrepresented.